Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia.
Ottaviano G, Georgiadis C, Gkazi SA, Syed F, Zhan H, Etuk A, Preece R, Chu J, Kubat A, Adams S, Veys P, Vora A, Rao K, Qasim W; TT52 CRISPR-CAR group. Ottaviano G, et al. Among authors: preece r. Sci Transl Med. 2022 Oct 26;14(668):eabq3010. doi: 10.1126/scitranslmed.abq3010. Epub 2022 Oct 26. Sci Transl Med. 2022. PMID: 36288281 Clinical Trial.
Base-Edited CAR7 T Cells for Relapsed T-Cell Acute Lymphoblastic Leukemia.
Chiesa R, Georgiadis C, Syed F, Zhan H, Etuk A, Gkazi SA, Preece R, Ottaviano G, Braybrook T, Chu J, Kubat A, Adams S, Thomas R, Gilmour K, O'Connor D, Vora A, Qasim W; Base-Edited CAR T Group. Chiesa R, et al. Among authors: preece r. N Engl J Med. 2023 Sep 7;389(10):899-910. doi: 10.1056/NEJMoa2300709. Epub 2023 Jun 14. N Engl J Med. 2023. PMID: 37314354 Clinical Trial.
Limits on the spin-dependent WIMP-nucleon cross sections from the first science run of the ZEPLIN-III experiment.
Lebedenko VN, Araújo HM, Barnes EJ, Bewick A, Cashmore R, Chepel V, Currie A, Davidge D, Dawson J, Durkin T, Edwards B, Ghag C, Horn M, Howard AS, Hughes AJ, Jones WG, Joshi M, Kalmus GE, Kovalenko AG, Lindote A, Liubarsky I, Lopes MI, Lüscher R, Lyons K, Majewski P, Murphy AS, Neves F, da Cunha JP, Preece R, Quenby JJ, Scovell PR, Silva C, Solovov VN, Smith NJ, Smith PF, Stekhanov VN, Sumner TJ, Thorne C, Walker RJ; ZEPLIN-III. Lebedenko VN, et al. Among authors: preece r. Phys Rev Lett. 2009 Oct 9;103(15):151302. doi: 10.1103/PhysRevLett.103.151302. Epub 2009 Oct 8. Phys Rev Lett. 2009. PMID: 19905617 Free article.
Long-term risk prediction after major lower limb amputation: 1-year results of the PERCEIVE study.
Gwilym BL, Pallmann P, Waldron CA, Thomas-Jones E, Milosevic S, Brookes-Howell L, Harris D, Massey I, Burton J, Stewart P, Samuel K, Jones S, Cox D, Clothier A, Prout H, Edwards A, Twine CP, Bosanquet DC; Vascular and Endovascular Research Network (VERN) and the PERCEIVE study group. Gwilym BL, et al. BJS Open. 2024 Jan 3;8(1):zrad135. doi: 10.1093/bjsopen/zrad135. BJS Open. 2024. PMID: 38266124 Free PMC article.
123 results